# Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

> **NCT00120510** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 816 (actual)

## Conditions studied

- HIV Infections
- Tuberculosis

## Interventions

- **DRUG:** Efavirenz
- **DRUG:** Lamivudine/Zidovudine

## Key facts

- **NCT ID:** NCT00120510
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 816 (ACTUAL)
- **Last updated:** 2014-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00120510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00120510, "Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00120510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*